Background and methods Risk factors for recurrence of Crohn's disease
and the evidence for progress in reducing recurrence following resecti
on were reviewed. A Medline based literature review was carried out. R
esults and conclusion Only smoking has been confirmed as a significant
adverse risk factor for recurrence. Evidence for differing recurrence
rates in fibrostenosing disease and perforating disease is inconclusi
ve, but such a classification along with the endoscopic findings of re
currence may have a place in the analysis of therapeutic trials. Minim
al resectional surgery with clearing of only macroscopic disease seems
to be justified, with no clear benefits from different anastomotic te
chniques. Recent trials offer encouraging evidence of the usefulness o
f 5-aminosalicylic acid, particularly higher-dose regimens started ear
ly after resection, although the long-term benefits are uncertain. The
oral steroid, budesonide, offers a potent treatment with minimal side
-effects, but evidence of its prevention of recurrence is presently we
ak.